We invest in Therapeutics,
Bionova Capital is an independent, healthcare-specialized venture capital firm, having been investing in early-stage life science companies since 2015. Bionova Capital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.
Bionova Capital works closely with entrepreneurs to build leading companies with technologies and products transforming people’s health. We invest in seed rounds and typically bring additional investors to our portfolio companies to add value and mitigate risk. Learn more about our current portfolio across Europe.
We have developed a wide network across Europe that includes research institutes, incubators and accelerators. Through this network, we have access to a rich pipeline of potential investments.
Biovance Capital Partners is set to manage a new fund up to € 60 million supported by the European Investment Fund (EIF) to invest in early-stage biotech companies across Europe.
Delox raises new investment to launch breakthrough antimicrobial system.
Bionova Capital’s portfolio company Adapttech raises £2.3 million and launches new prosthetic-fitting technologies
Adapttech secures new investment to grow global sales and expand its product range to improve fitting of lower-limb protheses